ArticlePractical laboratory medicine2026
Comparison of pre-analytical properties of blood collection systems for the diagnosis of diabetes mellitus.
Article in Practical laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Proper pre-analytical handling of blood samples is essential for reliable glucose measurement and for the accurate diagnosis and monitoring of diabetes mellitus. This study aimed to compare glucose concentrations in serum, lithium heparin (Li-Heparin), sodium fluoride citrate (NaF-Citrate), and sodium fluoride (NaF) plasma. Methods: Blood samples from 45 healthy volunteers were collected in Li-Heparin, NaF-Citrate, and serum tubes. Serum was stored at room temperature (RT) for up to 30 min, Li-Heparin whole blood in an ice-water slurry, and NaF-Citrate and Li-Heparin whole blood at RT for up to 10 min. Glucose was measured using the Cobas 8000 c701 analyzer. Additionally, internal routine laboratory data (n > 85,000) were analysed following the switch from NaF to NaF-Citrate tubes in 2015. Results: NaF-Citrate plasma showed the highest positive deviations, up to 3.11% compared with both reference conditions. Li-Heparin plasma at RT was 1.17 % higher than Li-Heparin plasma on ice. Serum glucose did not differ significantly from Li-Heparin plasma on ice. In routine data, the introduction of NaF-Citrate tubes resulted in an average increase of 10.5% in measured glucose concentrations in 2016. Conclusion: Glucose concentrations measured in NaF-Citrate plasma and Li-Heparin plasma (ice or RT) within 30 min after blood collection are not comparable. According to ADA and WHO diagnostic criteria, switching to NaF-Citrate tubes increased the proportion of patients with impaired fasting glucose by 16.9% and impaired glucose tolerance by 8.8%. NaF-Citrate tubes are recommended when immediate centrifugation and plasma separation cannot be ensured.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.